ICD-10: H44.2D1

Degenerative myopia with foveoschisis, right eye

Additional Information

Clinical Information

Degenerative myopia with foveoschisis, specifically coded as H44.2D1 in the ICD-10 classification, is a condition characterized by significant changes in the structure of the eye due to progressive myopia. This condition can lead to various complications, including foveoschisis, which is the splitting of the fovea, the central part of the retina responsible for sharp vision. Below, we explore the clinical presentation, signs, symptoms, and patient characteristics associated with this diagnosis.

Clinical Presentation

Overview of Degenerative Myopia

Degenerative myopia, also known as pathological myopia, is a severe form of myopia that typically develops in childhood or early adulthood and progresses over time. It is associated with elongation of the eyeball and can lead to various retinal complications, including foveoschisis, retinal detachment, and choroidal neovascularization.

Foveoschisis

Foveoschisis occurs when the inner layers of the retina split, leading to a separation of the fovea from the underlying retinal layers. This condition can significantly impact visual acuity and is often seen in patients with high degrees of myopia.

Signs and Symptoms

Common Symptoms

Patients with degenerative myopia and foveoschisis may present with a range of symptoms, including:

  • Blurred Vision: Patients often report a gradual decline in visual acuity, particularly in the affected eye.
  • Metamorphopsia: Distortion of visual images, where straight lines appear wavy or bent.
  • Scotomas: Areas of lost or impaired vision, which can be central or peripheral.
  • Difficulty with Night Vision: Patients may experience increased difficulty seeing in low-light conditions.

Clinical Signs

During an ophthalmic examination, several signs may be observed:

  • Fundoscopic Findings: The presence of foveoschisis can be identified through fundoscopic examination, where the fovea may appear elevated or distorted.
  • Retinal Changes: Other signs of degenerative myopia, such as posterior staphyloma (a bulging of the back of the eye), can also be noted.
  • Optical Coherence Tomography (OCT): This imaging technique can reveal the extent of foveoschisis and any associated retinal changes, providing detailed cross-sectional images of the retina.

Patient Characteristics

Demographics

Degenerative myopia with foveoschisis typically affects:

  • Age: Most commonly diagnosed in young adults or middle-aged individuals, although it can begin in childhood.
  • Gender: There is no significant gender predisposition, but some studies suggest a slightly higher prevalence in females.

Risk Factors

Several factors may contribute to the development of degenerative myopia and foveoschisis:

  • Genetic Predisposition: A family history of myopia can increase the risk of developing degenerative forms.
  • Environmental Factors: Prolonged near work, such as reading or using digital devices, may exacerbate myopic progression.
  • Previous Eye Conditions: Individuals with a history of other ocular diseases may be at higher risk.

Comorbidities

Patients with degenerative myopia may also have other ocular conditions, including:

  • Choroidal Neovascularization: This can occur as a complication of degenerative myopia, leading to further vision loss.
  • Retinal Detachment: Increased risk due to structural changes in the retina.

Conclusion

Degenerative myopia with foveoschisis (ICD-10 code H44.2D1) presents a complex clinical picture characterized by specific symptoms and signs that can significantly impact a patient's quality of life. Early diagnosis and management are crucial to prevent further complications and preserve vision. Regular ophthalmic evaluations and imaging studies, such as OCT, are essential for monitoring the progression of the disease and implementing appropriate treatment strategies.

Description

Degenerative myopia with foveoschisis is a specific condition classified under the ICD-10 code H44.2D1. This code is part of the broader category of disorders affecting the globe of the eye, particularly those related to degenerative changes in the retina and surrounding structures. Below is a detailed clinical description and relevant information regarding this condition.

Clinical Description

Definition

Degenerative myopia, also known as pathological myopia, is a severe form of myopia (nearsightedness) characterized by excessive elongation of the eyeball, leading to various ocular complications. Foveoschisis refers to the splitting or separation of the fovea, the central part of the retina responsible for sharp vision, which can occur as a result of degenerative changes associated with myopia.

Pathophysiology

In degenerative myopia, the elongation of the eyeball can lead to structural changes in the retina, including thinning and stretching. This can result in the development of foveoschisis, where the foveal layer separates, potentially causing visual disturbances. The condition is often associated with other complications such as retinal detachment, choroidal neovascularization, and macular degeneration.

Symptoms

Patients with degenerative myopia and foveoschisis may experience:
- Blurred or distorted vision, particularly in the central visual field.
- Difficulty with visual acuity, which may worsen over time.
- Possible scotomas (blind spots) in the visual field.
- Symptoms of metamorphopsia, where straight lines appear wavy or distorted.

Diagnosis

Diagnosis typically involves a comprehensive eye examination, including:
- Visual acuity tests to assess the clarity of vision.
- Fundoscopy to visualize the retina and detect any structural changes.
- Optical coherence tomography (OCT), which provides detailed images of the retina and can confirm the presence of foveoschisis.
- Ultrasound biomicroscopy may also be used to evaluate the posterior segment of the eye.

Treatment

Management of degenerative myopia with foveoschisis may include:
- Monitoring: Regular follow-up examinations to monitor the progression of the condition.
- Surgical intervention: In cases where vision is significantly affected, surgical options such as vitrectomy or macular surgery may be considered to address foveoschisis and associated complications.
- Low vision rehabilitation: For patients with significant vision loss, rehabilitation services can help maximize remaining vision.

Coding and Billing

The ICD-10 code H44.2D1 specifically denotes degenerative myopia with foveoschisis in the right eye. Accurate coding is essential for proper billing and insurance reimbursement, as it reflects the specific nature of the condition being treated. The code falls under the broader category of H44, which encompasses various disorders of the globe.

  • H44.2D: This code represents degenerative myopia with foveoschisis but does not specify the eye.
  • H44.2D2: This code would indicate degenerative myopia with foveoschisis in the left eye.

Conclusion

Degenerative myopia with foveoschisis is a serious ocular condition that can lead to significant visual impairment. Early diagnosis and appropriate management are crucial to preserving vision and improving the quality of life for affected individuals. Regular monitoring and potential surgical interventions are key components of care for patients diagnosed with this condition. Understanding the specific ICD-10 coding, such as H44.2D1, is essential for healthcare providers in ensuring accurate documentation and billing practices.

Approximate Synonyms

Degenerative myopia with foveoschisis, specifically coded as H44.2D1 in the ICD-10 classification, is a condition characterized by progressive vision loss due to changes in the eye's structure, particularly affecting the retina. This condition can be referred to by various alternative names and related terms, which can help in understanding its implications and clinical context.

Alternative Names

  1. Pathological Myopia: This term is often used interchangeably with degenerative myopia, emphasizing the severe nature of the condition and its potential complications, including foveoschisis.

  2. Myopic Maculopathy: This term refers to the macular changes associated with high myopia, which can include foveoschisis as a significant complication.

  3. Foveoschisis: While this is a specific term describing the splitting of the fovea, it is often used in conjunction with degenerative myopia to describe the condition's manifestation.

  4. Degenerative Myopia with Retinal Schisis: This term highlights the retinal aspect of the condition, focusing on the schisis (splitting) that occurs in the retina.

  5. High Myopia with Foveal Detachment: This term can be used to describe the advanced stages of degenerative myopia where foveal detachment may occur alongside foveoschisis.

  1. ICD-10 Code H44.2: This is the broader category for degenerative myopia, which includes various subtypes and complications.

  2. Retinal Degeneration: A general term that encompasses various degenerative changes in the retina, including those seen in degenerative myopia.

  3. Chorioretinal Degeneration: This term refers to the degeneration of both the choroid and retina, which can occur in severe cases of myopia.

  4. Visual Impairment: A broader term that encompasses the potential outcomes of degenerative myopia, including reduced visual acuity and other vision-related issues.

  5. Macular Degeneration: While typically associated with age-related changes, this term can sometimes overlap with discussions of myopic changes in the macula.

Understanding these alternative names and related terms can aid healthcare professionals in accurately diagnosing and discussing the condition, as well as in coding for insurance and treatment purposes. Each term emphasizes different aspects of the condition, from its pathological nature to its specific retinal implications.

Diagnostic Criteria

Degenerative myopia with foveoschisis, classified under ICD-10 code H44.2D1, is a specific condition that requires careful diagnostic criteria to ensure accurate coding and treatment. Below, we explore the criteria used for diagnosing this condition, including clinical features, diagnostic tests, and relevant considerations.

Understanding Degenerative Myopia with Foveoschisis

Definition

Degenerative myopia is a progressive eye condition characterized by excessive elongation of the eyeball, leading to various complications, including foveoschisis. Foveoschisis refers to the splitting of the retinal layers at the fovea, which can result in visual impairment.

Clinical Features

The diagnosis of degenerative myopia with foveoschisis typically involves the following clinical features:

  • Visual Symptoms: Patients may report blurred vision, distortion, or a decrease in visual acuity. These symptoms are often progressive and can significantly impact daily activities.
  • Fundoscopic Examination: An ophthalmologist will perform a detailed examination of the retina. Key findings may include:
  • Thinning of the retina
  • Presence of foveoschisis, which appears as a separation of the retinal layers at the fovea
  • Other degenerative changes such as lacquer cracks or chorioretinal atrophy

Diagnostic Tests

To confirm the diagnosis of degenerative myopia with foveoschisis, several diagnostic tests may be employed:

  • Optical Coherence Tomography (OCT): This non-invasive imaging technique provides cross-sectional images of the retina, allowing for the visualization of foveoschisis and other retinal changes associated with degenerative myopia.
  • Fundus Photography: High-resolution images of the retina can help document the extent of degenerative changes and monitor progression over time.
  • Visual Field Testing: This may be performed to assess any peripheral vision loss, which can occur in advanced cases of degenerative myopia.

Additional Considerations

  • Patient History: A thorough medical and ocular history is essential. Family history of myopia or related conditions may also be relevant.
  • Age and Risk Factors: Degenerative myopia typically manifests in young adults and can be influenced by genetic predisposition and environmental factors, such as prolonged near work.

Conclusion

The diagnosis of degenerative myopia with foveoschisis (ICD-10 code H44.2D1) relies on a combination of clinical evaluation, imaging studies, and patient history. Accurate diagnosis is crucial for appropriate management and treatment, which may include monitoring, surgical intervention, or other therapeutic options depending on the severity of the condition. If you have further questions or need more specific information regarding treatment options or management strategies, feel free to ask!

Treatment Guidelines

Degenerative myopia with foveoschisis, classified under ICD-10 code H44.2D1, is a complex ocular condition characterized by progressive degeneration of the retina and associated structures, leading to the formation of foveoschisis, particularly in the right eye in this case. This condition can significantly impact vision and requires a multifaceted treatment approach. Below, we explore standard treatment strategies for managing this condition.

Understanding Degenerative Myopia and Foveoschisis

What is Degenerative Myopia?

Degenerative myopia, also known as pathological myopia, is a severe form of myopia (nearsightedness) that typically progresses over time. It is associated with structural changes in the eye, including elongation of the eyeball, thinning of the retina, and potential complications such as retinal detachment and foveoschisis, which is the splitting of the retinal layers at the fovea.

What is Foveoschisis?

Foveoschisis occurs when the inner layers of the retina separate from the outer layers at the fovea, leading to visual distortion and loss of central vision. This condition is often seen in patients with high myopia and can be exacerbated by other retinal changes.

Standard Treatment Approaches

1. Monitoring and Regular Eye Exams

Regular monitoring by an ophthalmologist is crucial for patients with degenerative myopia. This includes:
- Comprehensive Eye Exams: To assess the progression of myopia and the status of the retina.
- Optical Coherence Tomography (OCT): This imaging technique helps visualize the retinal layers and monitor changes in foveoschisis.

2. Corrective Lenses

  • Prescription Glasses or Contact Lenses: These are often the first line of treatment to correct refractive errors associated with myopia. However, they do not address the underlying degenerative changes.

3. Surgical Interventions

In cases where foveoschisis leads to significant vision impairment or is at risk of complications, surgical options may be considered:
- Vitrectomy: This surgical procedure involves removing the vitreous gel from the eye, which can relieve traction on the retina and potentially improve vision.
- Retinal Repair Techniques: If there are associated retinal tears or detachments, procedures such as laser photocoagulation or scleral buckling may be necessary to stabilize the retina.

4. Pharmacological Treatments

  • Anti-VEGF Injections: In cases where there is associated choroidal neovascularization (abnormal blood vessel growth), anti-VEGF (vascular endothelial growth factor) injections may be used to reduce fluid accumulation and prevent further vision loss.

5. Lifestyle Modifications

  • Visual Hygiene: Encouraging patients to take regular breaks during prolonged near work and to maintain proper lighting can help manage symptoms.
  • Nutritional Support: A diet rich in antioxidants and omega-3 fatty acids may support overall eye health, although specific dietary interventions for degenerative myopia are still under investigation.

6. Low Vision Rehabilitation

For patients experiencing significant vision loss, low vision rehabilitation services can provide strategies and tools to maximize remaining vision and improve quality of life.

Conclusion

The management of degenerative myopia with foveoschisis (ICD-10 code H44.2D1) requires a comprehensive approach tailored to the individual patient's needs and the severity of their condition. Regular monitoring, corrective lenses, potential surgical interventions, and supportive therapies are essential components of care. Patients should work closely with their ophthalmologist to develop a personalized treatment plan that addresses both the structural changes in the eye and the functional implications for vision.

Related Information

Clinical Information

  • Blurred Vision a Common Symptom
  • Foveoschisis can lead to Visual Acuity Impairment
  • Metamorphopsia Distorts Visual Images
  • Scotomas can cause Areas of Lost Vision
  • Difficulty with Night Vision is common
  • Fundoscopic Findings reveal Foveoschisis
  • Retinal Changes include Posterior Staphyloma
  • OCT imaging provides detailed Retina Views
  • Age and Genetic Predisposition are Risk Factors
  • Environmental Factors exacerbate Myopic Progression

Description

  • Severe form of myopia characterized by excessive elongation
  • Excessive elongation leads to structural changes in retina
  • Foveal layer separates causing visual disturbances
  • Blurred or distorted vision particularly in central field
  • Difficulty with visual acuity which may worsen over time
  • Possible scotomas in visual field and metamorphopsia symptoms

Approximate Synonyms

  • Pathological Myopia
  • Myopic Maculopathy
  • Foveoschisis
  • Degenerative Myopia with Retinal Schisis
  • High Myopia with Foveal Detachment

Diagnostic Criteria

  • Blurred vision or distortion
  • Decrease in visual acuity
  • Thinning of retina on fundoscopy
  • Presence of foveoschisis on fundoscopy
  • Lacquer cracks or chorioretinal atrophy
  • Visual field loss in advanced cases
  • Family history of myopia or related conditions
  • Prolonged near work as risk factor

Treatment Guidelines

  • Regular eye exams every 6-12 months
  • Corrective lenses or contact lenses
  • Optical Coherence Tomography (OCT) scans
  • Vitrectomy in severe cases of foveoschisis
  • Anti-VEGF injections for choroidal neovascularization
  • Lifestyle modifications including visual hygiene
  • Low vision rehabilitation services

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.